ASX News
Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals
HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| AAS +AAT ABQ ARJ ARR (ASX) 20200701 CDE BCO BIC CEG CMQ CMR CNC CPK CWH CXH GNB GXG HDI IPA IUL MCH BGC NOC OAK ORH PMX PNM PRC PTN QIL QMG QST RCM RMA RNG STI SVC TIM ULT VGP VIR WFL WTG WWG | Ann: Annual Listing Fees- Suspension from Officia | 13/09/11 | 7 | 21K | |||
|
|||||||
| BCO +CEG CMQ CXH GNB HDI NOC PMX PNM PRC TIM VIR WFL | Ann: Annual Listing Fees - Removal from Official | 30/08/11 | 0 | 3.6K | |||
|
|||||||
| GNB | Ann: Change of Director's Interest Notice | 02/08/11 | 0 | 1.2K | |||
|
|||||||
| GNB | Ann: Change of Director's Interest Notice | 02/08/11 | 0 | 1.3K | |||
|
|||||||
| GNB | Ann: Change of Director's Interest Notice | 02/08/11 | 0 | 1.3K | |||
|
|||||||
| GNB | Ann: GNB announces focus on energy management tec | 01/08/11 | 0 | 1.1K | |||
|
|||||||
| GNB | Ann: Cleansing Statement | 29/07/11 | 0 | 1.1K | |||
|
|||||||
| GNB | Ann: Appendix 3B | 29/07/11 | 0 | 1.1K | |||
|
|||||||
See All Discussions
